BRIEF published on 04/28/2026 at 20:40, 2 days 1 hour ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 2 days 1 hour ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
PRESS RELEASE published on 04/28/2026 at 20:35, 2 days 1 hour ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 19, 2026, in Paris. Shareholders can access preparatory documents online. Meeting details and documents available on company website Annual General Meeting Shareholders Preparatory Documents Meeting Details GenSight Biologics
BRIEF published on 04/07/2026 at 19:04, 23 days 2 hours ago GenSight Biologics Reports Cash Status and Early Access Revenues Revenue Cash Position Gene Therapy GenSight Biologics Early Access Program
BRIEF published on 04/07/2026 at 19:04, 23 days 2 hours ago GenSight Biologics: Financial Update and Progress on AAC Fundraising Treasury Gene Therapy GenSight Biologics Compassionate Access
PRESS RELEASE published on 04/07/2026 at 18:59, 23 days 2 hours ago Inside Information / News release on accounts, results GenSight Biologics reports cash position and revenue from early access program as of March 31, 2026. Operating cash burn, fundraising, and treatment proceeds highlighted Revenue Fundraising Cash Position GenSight Biologics Early Access Program
BRIEF published on 03/27/2026 at 07:35, 1 month 3 days ago GenSight Biologics Reports 2025 Financial Performance Financing Activities Cash Runway R&D Expenses Regulatory Milestones Financial Results 2025
PRESS RELEASE published on 03/27/2026 at 07:30, 1 month 3 days ago Inside Information / News release on accounts, results GenSight Biologics reported estimated full-year consolidated financial results for 2025, highlighting key regulatory milestones achieved and cash runway projection through December 2026 Financial Results Phase III Trial GenSight Biologics Cash Runway Regulatory Milestones
BRIEF published on 03/23/2026 at 09:53, 1 month 7 days ago Heights Capital Management exceeds 8% of GENSIGHT BIOLOGICS' capital Capital Increase Threshold Crossing GenSight Biologics Capital And Voting Rights Heights Capital
BRIEF published on 03/18/2026 at 10:20, 1 month 12 days ago GenSight Biologics finalizes its €1.7 million fundraising round Ordinary Shares Fundraising GenSight Biologics Gene Therapies Risk Factors
Published on 04/30/2026 at 21:00, 47 minutes ago Datavault AI Schedules Conference Call to Discuss First Quarter 2026 Financial Results on Friday, May 15, 2026
Published on 04/30/2026 at 19:00, 2 hours 47 minutes ago Caldwell Announces Appointment of Shawn Banerji as Co-Leader of Technology Practice
Published on 04/30/2026 at 16:00, 5 hours 47 minutes ago CORRECTION FROM SOURCE: Rio Grande Resources Announces Results from its Airborne Survey at Winston Gold/Silver Project, New Mexico and Announces New President
Published on 04/30/2026 at 15:35, 6 hours 12 minutes ago Nepra Foods Enters Letter of Intent to Acquire Idaho Bottling and Water Assets, Advancing Vertical Integration Strategy
Published on 04/30/2026 at 15:10, 6 hours 37 minutes ago Formation Metals Announces Non-Brokered Offering of up to $15 Million Fully Allocated
Published on 04/30/2026 at 19:00, 2 hours 46 minutes ago DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 2 hours 47 minutes ago BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
Published on 04/30/2026 at 18:59, 2 hours 47 minutes ago Sirma Group Holding published its Invitation for Annual Regular General Shareholder Meeting
Published on 04/30/2026 at 18:41, 3 hours 5 minutes ago Ørsted completes divestment of its European onshore business
Published on 04/30/2026 at 18:41, 3 hours 6 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 04/30/2026 at 20:00, 1 hour 46 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 hours 31 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 hours 47 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 hours 37 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
